718 related articles for article (PubMed ID: 10584762)
1. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.
Emsley RA; Oosthuizen PP; Joubert AF; Roberts MC; Stein DJ
J Clin Psychiatry; 1999 Nov; 60(11):747-51. PubMed ID: 10584762
[TBL] [Abstract][Full Text] [Related]
2. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
Nkam I; Langlois-Thery S; Dollfus S; Petit M
Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
[TBL] [Abstract][Full Text] [Related]
3. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
[TBL] [Abstract][Full Text] [Related]
4. [Influence of resistance to voices on depression].
Monestès JL; Vavasseur-Desperriers J; Villatte M; Denizot L; Loas G; Rusinek S
Encephale; 2015 Feb; 41(1):25-31. PubMed ID: 24815790
[TBL] [Abstract][Full Text] [Related]
5. Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia.
Naidu K; van Staden WC; van der Linde M
BMC Psychiatry; 2014 Jun; 14():166. PubMed ID: 24903304
[TBL] [Abstract][Full Text] [Related]
6. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
7. Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression: a comparative analysis.
Rosen C; Marvin R; Reilly JL; Deleon O; Harris MS; Keedy SK; Solari H; Weiden P; Sweeney JA
Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):145-51. PubMed ID: 23006239
[TBL] [Abstract][Full Text] [Related]
8. Depression in first-episode schizophrenia.
Koreen AR; Siris SG; Chakos M; Alvir J; Mayerhoff D; Lieberman J
Am J Psychiatry; 1993 Nov; 150(11):1643-8. PubMed ID: 8105706
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.
Strous RD; Maayan R; Lapidus R; Stryjer R; Lustig M; Kotler M; Weizman A
Arch Gen Psychiatry; 2003 Feb; 60(2):133-41. PubMed ID: 12578430
[TBL] [Abstract][Full Text] [Related]
10. Depressive symptoms in schizophrenia.
Zisook S; McAdams LA; Kuck J; Harris MJ; Bailey A; Patterson TL; Judd LL; Jeste DV
Am J Psychiatry; 1999 Nov; 156(11):1736-43. PubMed ID: 10553737
[TBL] [Abstract][Full Text] [Related]
11. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
Lindenmayer JP; Bossie CA; Kujawa M; Zhu Y; Canuso CM
Psychopathology; 2008; 41(4):264-70. PubMed ID: 18441528
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naïve patients with schizophrenia presenting with first episode psychosis.
Dai J; Du X; Yin G; Zhang Y; Xia H; Li X; Cassidy R; Tong Q; Chen D; Teixeira AL; Zheng Y; Ning Y; Soares JC; He MX; Zhang XY
Schizophr Res; 2018 Mar; 193():182-187. PubMed ID: 28651908
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
14. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study.
Kendler KS; McGuire M; Gruenberg AM; Walsh D
Am J Psychiatry; 1995 May; 152(5):755-64. PubMed ID: 7726316
[TBL] [Abstract][Full Text] [Related]
15. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
Tollefson GD; Andersen SW
J Clin Psychiatry; 1999; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
[TBL] [Abstract][Full Text] [Related]
16. Item response analysis of the Positive and Negative Syndrome Scale.
Santor DA; Ascher-Svanum H; Lindenmayer JP; Obenchain RL
BMC Psychiatry; 2007 Nov; 7():66. PubMed ID: 18005449
[TBL] [Abstract][Full Text] [Related]
17. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis.
Emsley R; Rabinowitz J; Torreman M;
Schizophr Res; 2003 May; 61(1):47-57. PubMed ID: 12648735
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
19. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR
JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
